Newsletter
Sign up for the Fund's newsletter and get the lastest news, calls and events
| Titel Sort descending | Periode | Program | |
|---|---|---|---|
| CGCT Center for Gene and Cellular Therapy, Aarhus University & Aarhus University Hospital | 2022 - 2027 | Grand Solutions
|
|
|
CGCT Center for Gene and Cellular Therapy, Aarhus University & Aarhus University Hospital
Period
2022 - 2027
Region
Region Midtjylland Program
Grand Solutions Area
Ikke defineret Investment
Percentage
68.35 Invested
25.0 mill. Budget
36.6 mill. Partners
Aarhus University Hospital, Aarhus University, NectsGen, Scinus cell expansion BV, BioneerA/S, Copenhagen University Hospital (Rigshospitalet), Aalborg University, Erasmus Medical Centre Rotterdam, ChemoMetec A/S People
Region Midtjylland
Read more about the project
| |||
| CGM - Non invasive Continuous blood Glucose Measurements using THz-technology | 2023 - 2024 | Innoexplorer
|
|
|
CGM - Non invasive Continuous blood Glucose Measurements using THz-technology
Period
2023 - 2024
Region
Program
Innoexplorer Area
Ikke defineret Investment
Percentage
100 Invested
1.5 mill. Budget
1.5 mill. Partners
Danmarks Tekniske Universitet People
Read more about the project
| |||
| CGM-Augmented Insulin Pens for People with Type 2 Diabetes | 2016 - 2019 | Industrial Researcher
|
|
|
CGM-Augmented Insulin Pens for People with Type 2 Diabetes
Period
2016 - 2019
Region
Region Hovedstaden Program
Erhvervsforsker Area
Produktion, Materialer, Digitalisering og IKT Investment
Percentage
40.69 Invested
1.1 mill. Budget
2.6 mill. Partners
Technical University of Denmark, NOVO NORDISK A/S People
NOVO NORDISK A/S
Read more about the project
| |||
| Chabber Freelance Matcher | 2018 - 2019 | Innobooster
|
|
|
Chabber Freelance Matcher
Period
2018 - 2019
Region
Region Hovedstaden Program
Innobooster Area
Ikke defineret Investment
Percentage
33 Invested
475.200 Budget
1.4 mill. Partners
Chabs ApS People
Chabs ApS
Read more about the project
| |||
| Challenges and support needs among families affected by multiple sclerosis | 2024 - 2027 | Industrial Researcher
|
|
|
Challenges and support needs among families affected by multiple sclerosis
Period
2024 - 2027
Region
Program
Erhvervsforsker Area
Ikke defineret Investment
Percentage
45.23 Invested
1.1 mill. Budget
2.4 mill. Forskning i hvordan multipel sclerose (MS) påvirker børnefamilien som helhed samt hvordan familier kan støttes bedst muligt er stort set et uudforsket område. Med afsæt i et mixed-methods design undersøger nærværende ph.d.-projekt, hvordan børnefamilier påvirkes og kan støttes til bedre trivsel, når en forælder har MS. Dette gøres gennem tre delstudier, der udmunder i metoder, værktøjer og et koncept for en familie-centreret indsats til familier med MS.
Partners
University of Southern Denmark, SCLEROSEFORENINGEN People
Read more about the project
| |||
| Changes in sensory processing as biomarkers for dementia - the role of tau | 2019 - 2022 | Industrial Researcher
|
|
|
Changes in sensory processing as biomarkers for dementia - the role of tau
Period
2019 - 2022
Region
Region Hovedstaden Program
Erhvervsforsker Area
Biotek, Medico og Sundhed Investment
Percentage
57.01 Invested
1.1 mill. Budget
1.9 mill. Partners
University of Copenhagen, H LUNDBECK A/S People
H LUNDBECK A/S
Read more about the project
| |||
| Changing the way garments are made | 2018 - 2019 | Innobooster
|
|
|
Changing the way garments are made
Period
2018 - 2019
Region
Region Hovedstaden Program
Innobooster Area
Ikke defineret Investment
Percentage
33 Invested
497.475 Budget
1.5 mill. Partners
Rodinia ApS People
Rodinia ApS
Read more about the project
| |||
| Changing the way garments are made -v2- | 2020 - 2021 | Innobooster
|
|
|
Changing the way garments are made -v2-
Period
2020 - 2021
Region
Region Hovedstaden Program
Innobooster Area
Ikke defineret Investment
Percentage
33 Invested
905.224 Budget
2.7 mill. Partners
Rodinia ApS People
Rodinia Generation ApS
Read more about the project
| |||
| Changing The World Of Airport Planning | 2016 - 2018 | Innobooster
|
|
|
Changing The World Of Airport Planning
Period
2016 - 2018
Region
Region Hovedstaden Program
Innobooster Area
Ikke defineret Investment
Percentage
33 Invested
2.6 mill. Budget
7.8 mill. Partners
COPENHAGEN OPTIMIZATION ApS People
COPENHAGEN OPTIMIZATION ApS
Read more about the project
| |||
| Character Animation for Computer Games with Big Data | 2018 - 2021 | Industrial Researcher
|
|
|
Character Animation for Computer Games with Big Data
Period
2018 - 2021
Region
Region Hovedstaden Program
Erhvervsforsker Area
Produktion, Materialer, Digitalisering og IKT Investment
Percentage
28.63 Invested
1.1 mill. Budget
3.7 mill. Partners
University of Copenhagen, IO INTERACTIVE A/S People
IO INTERACTIVE A/S
Read more about the project
| |||
| Characterisation and modulation of neuropsychiatric disturbances in preclinical mouse model(s) of Alzheimer’s disease | 2017 - 2021 | Industrial Researcher
|
|
|
Characterisation and modulation of neuropsychiatric disturbances in preclinical mouse model(s) of Alzheimer’s disease
Period
2017 - 2021
Region
Region Hovedstaden Program
Erhvervsforsker Area
Biotek, Medico og Sundhed Investment
Percentage
80.97 Invested
1.1 mill. Budget
1.3 mill. Partners
Aarhus University, H. LUNDBECK A/S People
H. LUNDBECK A/S
Read more about the project
| |||
| Characterisation and optimisation of Escherichia coli cell factories for large-scale industrial production of Human Milk Oligosaccharides | 2019 - 2022 | Industrial Researcher
|
|
|
Characterisation and optimisation of Escherichia coli cell factories for large-scale industrial production of Human Milk Oligosaccharides
Period
2019 - 2022
Region
Region Hovedstaden Program
Erhvervsforsker Area
Bioressourcer, Fødevarer og Livsstil Investment
Percentage
47.35 Invested
1.1 mill. Budget
2.3 mill. Partners
Technical University of Denmark, Glycom A/S People
Glycom A/S
Read more about the project
| |||
| Characterisation of antibodies to insulin and investigation of their influence on treatment outcome in diabetic patients | 2017 - 2020 | Industrial Researcher
|
|
|
Characterisation of antibodies to insulin and investigation of their influence on treatment outcome in diabetic patients
Period
2017 - 2020
Region
Region Hovedstaden Program
Erhvervsforsker Area
Biotek, Medico og Sundhed Investment
Percentage
48.4 Invested
1.1 mill. Budget
2.2 mill. Partners
University of Copenhagen, Novo Nordisk A/S People
Novo Nordisk A/S
Read more about the project
| |||
| Characterization and mitigation of biological determinants of neuroinflammation and dysmyelination | 2024 - 2027 | Industrial Researcher
|
|
|
Characterization and mitigation of biological determinants of neuroinflammation and dysmyelination
Period
2024 - 2027
Region
Program
Erhvervsforsker Area
Ikke defineret Investment
Percentage
51.54 Invested
1.1 mill. Budget
2.1 mill. Multipel sklerose er en kronisk sygdom, hvor myelin omkring nerverne nedbrydes. At fremme myelinisering kan potentielt mindske sygdomsforløbet. Dette projekt sigter mod at identificere og karakterisere myelin-associerede gliasubpopulationer i væv fra patienter og musemodeller. Formålet er at finde translationsmarkører, der kan forudsige myelinisering, samt undersøge effekten af nuværende og eksperimentelle farmakologiske behandlinger på disse subpopulationer for at styrke lægemiddeludvikling.
Partners
University of Copenhagen, H LUNDBECK A/S People
Read more about the project
| |||
| Characterization of a PD-L1-based cancer vaccine in vivo | 2016 - 2019 | Industrial Researcher
|
|
|
Characterization of a PD-L1-based cancer vaccine in vivo
Period
2016 - 2019
Region
Region Hovedstaden Program
Erhvervsforsker Area
Ikke defineret Investment
Percentage
20.91 Invested
572.904 Budget
2.7 mill. Partners
University of Copenhagen, IO Biotech Aps People
IO Biotech Aps
Read more about the project
| |||